In cancer care, every hour a patient spends getting treatment is an hour away from the rest of their life. It could mean another afternoon in an infusion chair instead of at home. Another childcare arrangement to make. More missed work. Another exhausting drive to a distant treatment center.

Medical advances that turn a seven-hour infusion into a minutes-long injection make living with cancer dramatically less punishing. 

China is quietly seizing the Atlantic’s most critical gateway — and Washington is fast asleep

Dead men don’t need groceries: The fraud Democrats are suing to protect

Millions of Americans are saving billions with debt relief — so lenders are trying to block it

Medicare should encourage that kind of progress. Unfortunately, a new proposal from the Centers for Medicare & Medicaid Services could instead discourage it.

CMS is proposing to change how it classifies original intravenous biologics and newer subcutaneous, or injectable, versions of those drugs under Medicare’s Drug Price Negotiation Program. Developing a version of a complex biologic that can be safely administered through a brief injection rather than hours of intravenous infusion is not cheap. It can require years of research, clinical testing, and........

© Washington Examiner